These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20539229)

  • 21. Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy.
    Amara AB; Sharma A; Alexander JL; Alfirevic A; Mohiuddin A; Pirmohamed M; Close GL; Grime S; Maltby P; Shawki H; Heyworth S; Shenkin A; Smith L; Sharma AK; Hammad A; Rustom R
    Transplantation; 2010 Jan; 89(1):104-14. PubMed ID: 20061926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening and management of metabolic acidosis in patients with chronic kidney disease].
    Georges B; Huart J; Krzesinski JM; Jouret F
    Rev Med Suisse; 2018 Aug; 14(615):1455-1458. PubMed ID: 30136461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of metabolic acidosis in patients with chronic kidney disease (CKD)].
    Dębowska M; Przedlacki J
    Wiad Lek; 2017; 70(6 pt 2):1197-1200. PubMed ID: 29533913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Continuum of Acid Stress.
    Wesson DE
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1292-1299. PubMed ID: 33741720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.
    Wesson DE; Buysse JM; Bushinsky DA
    J Am Soc Nephrol; 2020 Mar; 31(3):469-482. PubMed ID: 31988269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alkaline Diet: a Novel Nutritional Strategy in Chronic Kidney Disease?
    Yari Z; Mirmiran P
    Iran J Kidney Dis; 2018 Jul; 12(4):204-208. PubMed ID: 30087214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential benefits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the management of CKD.
    Sahni V; Rosa RM; Batlle D
    Kidney Int; 2010 Dec; 78(11):1065-7. PubMed ID: 21076447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional renal reserve capacity in different stages of chronic kidney disease.
    Barai S; Gambhir S; Prasad N; Sharma RK; Ora M
    Nephrology (Carlton); 2010 Apr; 15(3):350-3. PubMed ID: 20470306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic acidosis and progression of chronic kidney disease: incidence, pathogenesis, and therapeutic options.
    Ortega LM; Arora S
    Nefrologia; 2012; 32(6):724-30. PubMed ID: 23169354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acidosis: progression of chronic kidney disease and quality of life.
    de-Brito Ashurst I; O'Lone E; Kaushik T; McCafferty K; Yaqoob MM
    Pediatr Nephrol; 2015 Jun; 30(6):873-9. PubMed ID: 25085611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?
    Mannon EC; O'Connor PM
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1090-F1104. PubMed ID: 33166183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
    Brandenburg V; Floege J
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():158-62. PubMed ID: 16802544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute metabolic acidosis enhances circulating parathyroid hormone, which contributes to the renal response against acidosis in the rat.
    Bichara M; Mercier O; Borensztein P; Paillard M
    J Clin Invest; 1990 Aug; 86(2):430-43. PubMed ID: 2166755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A;
    Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Acidosis in CKD: Core Curriculum 2019.
    Raphael KL
    Am J Kidney Dis; 2019 Aug; 74(2):263-275. PubMed ID: 31036389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between serum phosphorus and the progression of advanced chronic kidney disease.
    Caravaca F; Villa J; García de Vinuesa E; Martínez del Viejo C; Martínez Gallardo R; Macías R; Ferreira F; Cerezo I; Hernández-Gallego R
    Nefrologia; 2011; 31(6):707-15. PubMed ID: 22130287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of chronic kidney disease among older adults: a focus on the oldest old.
    Bowling CB; Muntner P
    J Gerontol A Biol Sci Med Sci; 2012 Dec; 67(12):1379-86. PubMed ID: 22960475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A
    J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.